- Exchanges
- BSE, NSE
- Industry
- Specialty Chemicals
- Issue
- Book building
Tatva Chintan Pharma Chem IPO
₹2,312.20
+113.50% on listing
Listing-day close · NSE · 29 Jul 2021 · issue price ₹1,083
Tatva Chintan Pharma Chem’s ₹500 crore IPO was priced at ₹1,083 a share. It listed on the NSE on 29 Jul 2021 and closed its first day at ₹2,312.20, up 113.50% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹500 Cr
- Fresh issue
- ₹225 Cr
- Offer for sale
- ₹275 Cr
- Lot size
- 13 shares
- Minimum investment
- ₹14,079
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 124.52× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹2,400 Cr
- Promoter holding
- 100.00% → 79.17%
From the offer documents.
Listing
- Listing date
- 29 Jul 2021
- Issue price
- ₹1,083
- Open
- ₹2,111.85
- High
- ₹2,534.20
- Low
- ₹2,111.85
- Close
- ₹2,312.20
Listing day on the NSE. The close was +113.50% on the issue price.
TATVA share price todayFAQs
When did the Tatva Chintan Pharma Chem IPO open and close?
It opened on 16 Jul 2021 and closed on 20 Jul 2021.
What was the Tatva Chintan Pharma Chem IPO price?
The price band was ₹1,073–1,083 a share. The final issue price was ₹1,083.
What is the lot size and minimum investment?
One lot is 13 shares, ₹14,079 at ₹1,083 a share. Retail investors apply in whole lots.
How much did Tatva Chintan Pharma Chem raise?
₹500 crore: ₹225 crore of new shares and ₹275 crore offered by existing shareholders.
How many times was the Tatva Chintan Pharma Chem IPO subscribed?
124.52 times overall.
How did Tatva Chintan Pharma Chem list?
It listed on the NSE on 29 Jul 2021 at ₹2,111.85 and closed the day at ₹2,312.20, up 113.50% on the ₹1,083 issue price.
Who is the registrar of the Tatva Chintan Pharma Chem IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app